In vivo administration of Canavalia brasiliensis lectin (at the time of infection, or maintained throughout the infection) reduced the lesions of highly susceptible BALB/c mice infected by Leishmania amazonensis. At the doses used C. brasiliensis lectin (ConBr) does not interfere with penetration or fate of Leishmania in the macrophages in vitro. Since Interferon-7 (IFN-J is the major rnacrophage activating factor, and considered a critical element in the successful immune response against leishmaniasis, we explored its participation in this phenomenon. ConBr either in vivo or in vitro induced IFN-~ production in normal or in leishmania-infected BALB/c mice. However we were unable to change the course of disease by in vivo IFN-), administration (although IFN-y preparations were effective in inducing a leishmanicidal effect in vitro on L. amazonensis-infected peritoneal macrophages). Additionally, IFN-~, neutralization with anti-IFN-), monoclonal antibody did not alter the protection conferred by ConBr administration. These data show that lectin administration in vivo is protective in the otherwise unchecked L. amazonensis infection of BALB/c mice, and suggest that such effect is not mediated by IFN-7. 
or L. donovani, respectively, by the use of anti-IFN-7 MAb (Belosevic et al., 1989; Squires et al., 1989) .
Several lectins are known as lymphocyte activators, inducing proliferation and lymphokine production. Some lectins, such as Con A from C. ensiformis, are standard reagents for in vitro lymphocyte studies. ConBr, from C. brasiliensis, stimulates lymphocytes inducing higher lymphocyte proliferative responses and IFN-~ production than several other lectins, including Con A (Barral-Netto et al., 1992b) . The use of some natural products in vivo results in lymphocyte stimulation, and may mediate important functions as prevention of malignant tumor outgrowth (Newell et al., 1991) . Recently orally administered lectins have been shown to stimulate human immune response (Luther et al., 1990) . Con A is also capable of inducing lymphocyte proliferation and IL-2 production when administered in vivo (Black et al., 1988) .
The mouse models of leishmaniasis reproduce different aspects of the human disease. Upon infection by L. amazonensis the highly susceptible BALB/c mice develop a severe disseminated disease, with fatal course, and this severity is paralleled by a lack of CMI responses against leishmania antigen. On the other hand, C57BL/6 mice when infected by the same parasite develop a single ulcerated lesion, which evolves to an apparent cure. Months after the initial infection, and coincident to the decline of CMI in the aging animals, the infected mice develop a metastatic disease, resembling mucocutaneous leishmaniasis (Barral et al., 1983) .
Based on the potent lymphocyte stimulatory capacity of ConBr we decided to evaluate its in vivo effect on the course of L. amazonensis infection in BALB/c mice, and a possible participation of IFN-7 in the process.
Material and methods
Animals. BALB/c mice were obtained from our own colony, maintained with commercial balanced mouse ration and water ad libitum. OF/1 mice were obtained from Institute Pasteur (Paris-France).
Parasites. L. amazonensis (MHOM/BR/76/Josefa) was used. Details of isolation, maintenance and course of disease in mice have been reported elsewhere (BarralNetto et al., 1987b) .
Infection. Stationary-phase promastigotes (5 x 106/animal) from modified liver infusion tryptose medium (Barral et al., 1987) were injected s.c. into the left hind footpad. Evolution of infection was monitored by weekly measurement of foot-pad thickness with a dial gauge caliper (Starret Co., Athol, MA). Differences between infected and contralateral uninfected footpad are referred as lesion size, in millimeters.
Leetin and treatment. ConBr was obtained according to the methods previously described (Moreira and Cavada, 1984) , and used at 100 lig per animal per dose, injected i.p.. Groups of 10 animals were either treated three times, at days -1, 0 and 1 of infection, or with weekly doses of the lectin during the whole period of observation. Untreated controls were injected i.p. at the same schedules with saline.
Interferon ?: Two preparations of IFN-~ were used. Recombinant murine IFN-y (5 × 106 IU/mg of protein; Genentech Corp., South San Francisco, CA), and recombinant rat IFN-7 (2.5 × 106 IU/mg; Institut Roussel Uclaf, Romainville, France). Rat IFN-7, used in vivo in mice, stimulates the respiratory burst of peritoneal macrophages at an optimal dose of 5000 IU/animal (Dr. Michel Lando, personal communication). Both preparations were administered subcutaneously.
Anti-IFN-? MAb: Mice were treated i.p. with 500 gg of neutralizing anti-IFN-7 antibody XMG 1.2 (rat IgG1) at time of infection, and with 300 gg three times a week during the whole period of observation.
Macrophage culture and in vitro infection: BALB/c resident peritoneal macrophages were washed 3 times in RPMI 1640, and resuspended, in RPMI 1640 with 10% heat inactivated FCS (fetal calf serum, GIBCO; Grand Island, NY). Five x l0 s to 2 x 106 cells/well were plated in 8 chamber Lab-Tek slides (Miles Laboratories, Naperville, IL) and incubated for 2 h at 37°C in a humid atmosphere of 5% CO2. Non-adherent cells were removed by repeated washings. The cultures were incubated with leishmania promastigotes at a ratio of 10:1 for 3 h at 35°C in 5% CO2 and 95% humidified air. Free parasites were then removed by extensive washings. Different IFN-y concentrations were added to duplicate wells in RPMI 1640 with 10% FCS. In some cultures ConBr was added, at different concentrations, before parasite exposure and maintained throughout the culture period. The slides were incubated for another 24 h followed by washings with PBS. The cells were fixed and stained with Diff Quick (American Scientific Laboratories, McGaw Park, IL). Infection was estimated by calculating the percentage of infected macrophages, as well as the number of parasites per 100 cells in duplicate cultures.
In vivo kinetics of radiolabelled IFN-y: rMu IFN-v was labelled with 125~ by the chloramine T method. Labelled IFN-7 had 1,6 x l0 7 CPM/ml and maintained its biological activity (1 x 104 IU/ml, as measured by a vesicular stomatitis virus (vsv) plaque reduction assay. Thirty female 6 to 7 week-old OF-1 mice were injected in the left hind footpad with 25 lal of radiolabelled IFN-7 solution and groups of 5 mice were sacrificed at 6 time points (time zero corresponding to sacrifice immediately after injection). Blood samples were heparinized and duplicate samples of 50 gl blotted on Whatman filter paper. Radioactivity was measured in one untreated sample, the other sample was incubated with 10% TCA for 15 min at 4°C. The 10% TCA solution was changed once, followed by two incubations with 5% TCA, and finally replaced by an alcohol ether (50/50 v/v) solution. Filter papers were collected, dried and counted. Both hind feet were obtained from each animal by sectioning above the joint and counted directly.
Stimulation of IFN-? production. For evaluation of in vivo IFN-y production 5 BALB/c mice were treated i.p. with ConBr (100 ~tg/animal) and had their blood collected 24 h later. IFN-7 was measured in serum, and compared to uninjected animals. For in vitro stimulation spleen cells were obtained from 3 normal BALB/c mice and cultured in RPMI 1640 (GIBCO, Grand Island, NY), supplemented with glutamine (100 mM), 2-ME (5 x 10 -5 M), penicillin (100 U/ml) and streptomycin (100 ~tg/ml), at a concentration of 5 x 106 cells/ml. Supernatants from either stim-ulated (ConBr 5 Ixg/ml) or unstimulated cultures (in duplicate) were harvested at 24 h for IFN-7 measurements. IFN-7 determination. IFN-y, either in serum or culture supernatant, was measured by a virus plaque reduction assay using L929 cells and Vesicular Stomatitis Virus. That the reduction was due to IFN-7 was demonstrated by inhibiting the anti-viral effect of the preparations by pre-treatment with XMG 1.2 MAb.
Histology. BALB/c mice from groups treated with lectin or controls (n -5 per group) were sacrificed at 5 and 8 weeks post-infection and infected foot-pads obtained. The material was fixed in formalin, embedded in paraffin and processed for hematoxylin and eosin staining.
Statistics. Group means were compared by the Mann-Whitney test, and differences were considered significant if p <0.05.
Results
Effect of in vivo leetin administration on lesion growth. Administration of ConBr to BALB/c mice during the time of their infection with L. amazonensis (1 day before, at the day of infection, and 1 day after) conferred a partial degree of protection to these animals, as compared to saline treated controls (Fig. 1) . Differences in lesion size between the two groups were statistically significant after the fifth week of infection. The prolonged use of ConBr, during the 8 weeks of observation, at a dose of 100 ~tg/animal/week, starting at the day of infection, resulted in a degree of protection similar to the one obtained with the use of the lectin at the time of infection only (data not shown).
Histopathalogy. At 5 weeks post-infection BALB/c ConBr-treated mice exhibited less parasites than saline-treated controls. Saline treated animals exhibited an intense inflammatory infiltrate represented by large vacuolated and heavily parasitized macrophages (Fig. 2 A,C) . Extensive areas of purulent necrosis and collections of neutrophils were also observed. The inflammatory infiltrate of ConBr-treated animals was composed of non-vacuolated macrophages and lymphocytes (Fig. 2 B,D) . There was proliferation of fibroblastic cells in the periphery of the lesion, and a discrete production of conjunctive tissue. At 8 weeks post-infection the histopathological differences between the two groups were even more marked. The inflammatory infiltrate of ConBr-treated animals exhibited a profound decrease in the number of parasitized macrophages, and a correspondent increase in the number of lymphocytes. The presence of fibrinoid necrosis was frequently observed; with fibrogenesis of moderate intensity and formation of thin septa towards the interior of the lesion. On the other hand, salinetreated animals exhibited an inflammatory infiltrate represented by vacuolated macrophages with an adipocyte-like appearance (approximately 60% of cells in the lesions) harboring a large number of parasites.
IFN-7 production. Table I shows that ConBr was able to induce IFN-), production by naive or leishmania-infected BALB/c spleen cells upon in vitro stimulation, and was also able to induce the appearance of IFN-v in the sera of animals injected i.p..
Effects of in vivo IFN-7 administration. Administration (subcutaneously, not at the site of the infection) of recombinant IFN-7 at the beginning of infection, three doses of either 5 × l03 (data not shown) or 2 x 104 IU/mouse/day at days -1, 0, and 1 of infection (Fig. 3, Panel A) , or weekly for the whole period of observation (Fig. 3 , Panel B) did not alter the course of L. amazonensis infection in BALB/c mice.
Kinetics of radiolabelled IFN-7: Serum kinetics of 125~ IFN-y (250 IU corresponding to 412.000 CPM/animal) is shown in Figure 4 . The material diffuses rapidly away from the injection site and 15 min after injection less than half the counts obtained at time zero were recovered from the injected foot pad, and radiolabelled IFN-y could be detected in the contralateral foot pad (2,315 and 1,962 CMP one and 2 h after injection). Radioactivity is also detected as a TCA-precipitable material in serum, showing that it is bound to a large molecule (insert of Fig. 4) . Considering that the 125I-labelled IFN-y contained 1 x 104 IU/ml with 1.6 x 107 CPM/ml, approximately 1 IU out of the 250 IU of IFN-7 injected reached the contralateral foot pad, in a few hours. Also according to these data, amounts greater than 10 U of IFN-y remained in the injected footpad for more than 7 h.
Use of IFN-7 in vitro: In 3 experiments both rRat and rMu IFN-7 were capable of inducing amastigote killing by mouse peritoneal macrophages. The effect was most marked at 1,000 IU/ml, but reduction of parasitism was statistically significant even at l0 IU/ml (Table II) . Another experiment showed that rMu IFN-v was more active than rRat IFN-y in inducing anti-leishmanial activity in murine macrophages (% reduction of parasitism of 58 vs 30, respectively, at a dose of 10 IU/ml).
Effect of ConBr on in vitro macrophage cultures. The presence of ConBr (1, 10 or 100 ~tg/ml) in macrophage cultures did not alter the rate of infection both as measured by the number of parasites per 100 macrophages, or by the percentage of infected cells, as compared to untreated cultures (Fig. 5) . The presence of ConBr (l0 ~tg/ml) in macrophage cultures infected with L. amazonensis also did not affect the anti-leishmanial activity of rMu IFN-7 (10 IU/ml). In rMu IFN-7-treated cultures the presence of ConBr resulted in reduction of parasitism of 65 and 63%, whereas cultures without ConBr reduction was of 68 and 64%.
Effect of anti-IFN-7 MAb. Groups of four BALB/c mice were treated with ConBr (100 pg/animal i.p. at days -1, 0 and 1 of infection) or with the same schedule of ConBr plus anti-IFN-v (500 ~tg/animal initially and 300 pg/animal/dose, i.p., of XMG 1.2 antibody, 3 times/week for 8 weeks); or treated with saline alone at the same intervals. The treatment with anti-IFN-7 MAb did not alter the protective effect induced by ConBr (Fig. 6 ).
Discussion
Our results show that in vivo administration of ConBr is able to protect, but not cure, the highly susceptible BALB/c mice against L. amazonensis infection. Such treatment also stimulated lymphocytes, as evidenced by IFN-7 production, and by the development of a histological pattern observed only in resistant mice, such as lymphocytic infiltration and fibrinoid necrosis (Andrade et al., 1984; Barral-Netto et al., 1987a ). In our model, however, IFN-y production and protection do not seem to be interlinked, since the use of anti-IFN-y MAb did not reduce the lectin-induced protection.
Other actions of the lectin, besides the production of IFN-~,, are probably responsible for such an effect. Con A, a lectin very similar to ConBr, has been shown to induce the increase in the number and size of lymphocytes, with the expression of IL-2R and spontaneous proliferation when administered in vivo (Black et al., 1988) . It is possible that many other, not explored, lymphocyte functions are involved in the protective effect. Whichever this effect was, it is remarkable that the use of the lectin just at time of infection was capable of achieving protection. The in vivo administration of Con A has a transient effect on the immune system, with return to normal parameters in approximately 24h (Black et al., 1988) , The immune activation during the critical period of infection is capable of altering the course of disease, without further improvement with the maintenance of activation for a longer period. The participation of glycoproteins in the process of penetration of leishmania into the macrophage has been shown (Bray, 1983) , what raises the possibility of a direct effect of the lectin, hindering the parasite entry into the host cell, and leading to its extracellular destruction. Although we cannot exclude this possibility, it seems unlikely. In our system the presence of the lectin did not change the penetration or fate of leishmania inside the macrophage in the in vitro cultures. Promastigote agglutination in vitro has been observed with several species of leishmania, but these studies were performed in sugar-free PBS, and even then agglutinating concentrations ranged from 50 ~tg/ml to 10 mg/ml (Dwyer, 1974; Jacobson et al., 1982) , concentrations far above those that could be achieved by the administration of 100 ~tg of lectin per animal.
The possibility of an immune response directed against the lectin itself reacting against possible cross-reacting parasite epitopes it is unlikely, but cannot be excluded. The presence of the lectin just for 3 days during the period of infection, given i.p. without adjuvant, is not likely to induce a potent immune response, and even if it does such a response would not be operative in such a short time.
We were not able to change the natural course of L. amazonensis infection in susceptible BALB/c mice by exogenously administered IFN-y, as has been shown for the infection with L. major (Sadick et al., 1990) . Despite these results we should consider the possibility that only IFN-y produced very early in infection is elemental for protection, and that ConBr administered before infection induced such a production. We have used IFN-7 starting one day before infection allowing for this possibility and observed no protection. Conversely, the use of anti-IFN-7 at time of infection did not change the protective effect obtained by the ConBr treatment.
Both IFN-? preparations used in this study were biologically active, as demonstrated by in vitro assays of intracellular killing of L. amazonensis in murine peritoneal macrophages. Based on our in vivo kinetics experiments (1 out of 250 IU reaching a site distant of injection) amounts greater of approximately 20 IU (for doses of 5,000 IU; data not shown) or 80 IU (for doses of 2 × 104 IU) of IFN-y were expected to have been reached in the lesion, which are similar to doses effective in vitro. The lack of in vivo activity of IFN-7 despite the evidence of in vitro effectiveness, as shown in the present study, was also observed in other systems (Van Dissel et al., 1987) . We cannot determine whether the contrasting findings between in vitro-treated peritoneal macrophages and in vivo-treated cutaneous macrophages at lesion sites are due to lack of proper stimulation or to a defective leishmanicidal capacity of cutaneous macrophages. Macrophages from footpad granulomas of Mycobacterium leprae-infected susceptible nu/nu mice could not be activated in vitro by IFN-7/MAF to kill or inhibit Toxoplasma gondii whereas peritoneal macrophage from the same mice were successfully activated (Sibley and Krahenbuhl, 1987) .
The evidence for an in vivo role of IFN-7 in murine models of cutaneous leishmaniasis is not as strong as shown in vitro. Resistant animals even when treated with anti-IFN-~ MAb were able to control lesion growth (Belosevic et al., 1989; Sadick et al., 1990) . Lymphoid cells from CBA mice naturally resistant or rendered susceptible by anti-CD4 MAb treatment exhibited mRNA coding for IFN-~ after L. majorinfection. Furthermore, only in the lesions of anti-CD4 treated mice showing uncontrolled growth was IFN-~ mRNA found (Muller et al., 1989) . Additionally, the use of generous amounts of IFN-~,, or the transfer of a cell which produces IFN-7 did not protect susceptible animals against cutaneous leishmaniasis (Sadick et al., 1990; Titus et al., 1991) . It has been shown that the use of anti-IFN-7 MAb do not alter the protection of BALB/c treated with anti-IL 4 (Sadick et al., 1990) , and also that immunized and protected BALB/c mice produce high levels of TNFc~ but not of IFN-~ (Boom et al., 1990; Theodos et al., 1991) . IFN-y does not seem to participate in the early regulation of visceral leishmaniasis in the mouse (Kaye and Bancroft, 1992) . Additionally, IL-4 production but not IFN-7 production correlated with severity of leishmaniasis when evaluated in thirteen inbred mouse strains covering the range of susceptibility to disease caused by L. major (Morris et al., 1993) .
The anti-leishmanial effect of IFN-7 used alone, against visceral leishrnaniasis, was augmented when combined with pentavalent antimonial (Murray, 1990) . It is possible that the beneficial effects of IFN-7 in leishmaniasis are due to a combined action with anti-leishmanial agents and not only through a direct leishmanicidal action (Badaro et al., 1990; Murray et al., 1988) . It is also possible that IFN-7 is more effective when used alone in visceral leishrnaniasis, either because L. donovani is more susceptible, or because liver and spleen macrophages (due to influences of neighbor cells or temperature, for example) are more responsive to the activating effects of IFN-y.
It should also be considered the possibility that other elements, which may synergize with IFN-2;, like TNF-~ Liew et al., 1990) , and GM-CSF Weiser et al., 1987; Handman and Burgess, 1979) , may also be lacking, and IFN-y alone is not suficient to induce protection in susceptible animals. Another possibility is the inhibition of the actions of IFN-y in animals susceptible to cutaneous leishmaniasis by a large production of cytokines like IL-10 or TGF-fl (Heinzel et al., 1991; Barral-Netto et al., 1992a; Barral et al., 1993) , explaining the failure of exogenously administered IFN-y.
Although the intra-peritoneal use of a lectin may not be feasible for enhancing anti-leishmania immune response, it is important that a natural product is able to have such an effect when used in vivo. It is noteworthy that ConBr is a highly abundant lectin in the seeds of a leguminous seed frequently used for human nutrition in Northeastern Brazil. The possibility of enhancing immune response by oral administration of ConBr, as has been shown for other lectin (Luther et al., 1990) , deserves further investigation.
